IgG-SARS-CoV-2-Imaxyz (IMAXYZ) ELISA Reagent Kit for the Detection of SARS-CoV-2 (COVID-19) IgG Antibodies in Human Serum (Plasma) According to TU 21.20.23-092-94568735-2020

IgG-SARS-CoV-2-Imaxyz (IMAXYZ) ELISA Reagent Kit for the Detection of SARS-CoV-2 (COVID-19) IgG Antibodies in Human Serum (Plasma) According to TU 21.20.23-092-94568735-2020

The "IgG-SARS-CoV-2-Imaxyz (IMAXYZ)" reagent kit is designed for the enzyme-linked immunosorbent assay (ELISA) detection of class G immunoglobulins (IgG) to the SARS-CoV-2 (COVID-19) virus in human blood serum or plasma.

Kit Components:

• Microplate – 1 pack
• Conjugate, 14 mL – 1 vial
• Negative control, 1.0 mL – 1 vial
• Positive control, 1.0 mL – 1 vial
• Buffer P, 24 mL – 1 vial
• Buffer A, 18 mL – 1 vial
• TMB solution, 14 mL – 1 vial
• Stop reagent, 14 mL – 1 vial
• Buffer B, 50 mL – 1 vial
• Resealable bag – 1 piece
• Sealing films for microplate – 2 pieces
• Reagent troughs – 2 pieces
• Disposable pipette tips – 16 pieces

All components comply with TU 21.20.23-092-94568735-2020.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, IgG-SARS-CoV-2-Imaxyz (IMAXYZ) ELISA Reagent Kit for the Detection of SARS-CoV-2 (COVID-19) IgG Antibodies in Human Serum (Plasma) According to TU 21.20.23-092-94568735-2020, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.